Chalmers, James D. et al
"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study." European Respiratory Journal
(2024):
2401551.
Web. 16 Jan. 2025.
